Figure 2. (A) Pie chart illustrating percentage of studies
analyzed that reported race as a patient characteristic. (B) Histogram
reporting the percentage of studies (of the studies that reported
multiple races) that reported participation rates of each race category.
(C) Histogram showing percent of studies published each year that
reported demographic data on participant race.
The white participants represented 82.55% (95% CI 80.39%-84.71%) of
study participants (Table 1) (Figure 3A). The mean rates of
participation of Asian, African American, Hispanic, Others, and Unknown
were 14.03% (95% CI 11.02%-17.04%), 5.53% (95% CI 4.50%-6.56%),
3.97% (95% CI 2.13%-5.81%), 3.99% (95% CI 3.21%-4.77%), and
2.46% (95% CI 0.85%-4.08%) respectively (p < 0.001)
(Table 1) (Figure 3A).
Table 1. Mean Rates of Participation of each Race across
analyzed Lung Cancer Phase III Clinical Trials.